Publication | Open Access
Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a study
47
Citations
19
References
2023
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1